Skip to main content
CVS
NYSE Trade & Services

CVS Beats on Revenue and EPS, Lifts 2026 Guidance, Confirms Two-Company Split

Tom Rudovsky · Reported by Reuters
More coverage: Consumer
Sentiment info
Positive
Importance info
9
Price
$93.2
Mkt Cap
$116.911B
52W Low
$69.51
52W High
$110.68
52W Position info
34% above low
Off High info
16% below high
Rel. Volume info
2.4× avg
Market data snapshot near publication time

CVS sits 34% above its 52-week low of $69.51 on elevated volume (2.4× avg).

Summary

CVS delivered a clean beat: Q3 revenue of $108.40 billion against a $104.69 billion consensus, and adjusted EPS of $2.09 versus $1.65 expected. Management raised full-year 2026 adjusted EPS guidance to at least $8.20 from $7.90-$8.10 and lifted cash flow from operations guidance to at least $15.5 billion from $11.5 billion — the cash flow jump is the biggest surprise in the release. The company also confirmed it will separate into two independent public companies, a healthcare solutions business and CVS Pharmacy, following yesterday's report that a retail pharmacy spin-off was under discussion. Segment detail explains the quarter: Health Services revenue rose 9.5% and Health Care Benefits adjusted operating income improved on the government business, while Pharmacy & Consumer Wellness revenue fell 2.0% on regulatory price reductions and reimbursement pressure — precisely the unit now being carved out. The split is targeted for the first half of 2028, so the near-term trade is the guidance raise, not the separation mechanics.

At the time of this announcement, CVS was trading at $93.20 on NYSE in the Trade & Services sector, with a market capitalization of approximately $116.9B. The 52-week trading range was $69.51 to $110.68. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

CVS - Latest Insights

CVS
Nov 04, 2026, 1:48 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $80.13
Real-time Price: $79.92 info
Change: -$0.2087 (-0.26%) info
Market Cap: $103.433B info
CVS
Nov 04, 2026, 6:34 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $91.86
Real-time Price: $79.92 info
Change: -$11.94 (-13%) info
Market Cap: $103.433B info
CVS
Nov 04, 2026, 6:31 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $91.49
Real-time Price: $79.92 info
Change: -$11.57 (-13%) info
Market Cap: $103.433B info
CVS
Nov 04, 2026, 6:30 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $91.84
Real-time Price: $79.92 info
Change: -$11.92 (-13%) info
Market Cap: $103.433B info
CVS
Nov 03, 2026, 5:35 PM EST
Source: Reuters
Importance Score:
9
Price at Filing: $94.00
Real-time Price: $79.92 info
Change: -$14.08 (-15%) info
Market Cap: $103.433B info